You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Adaptive Mapping of the Gulf Dead Zone with AutonomousSurface Vehicles
SBC: Autonomous Surface Vehicles (ASV), LLC Topic: 827TECHNICAL ABSTRACT: Gliders alone are incapable of monitoring the shallower regions of the hypoxic zone under conditions when the density gradient is strong, therefore surface vehicles are required to autonomously collect a suite of oceanographic observations from surface waters and profile this portion of the hypoxic zone. Autonomous Surface Vehicles, LLC (ASV, LLC) is partnering with Integral Co ...
SBIR Phase I 2018 Department of CommerceNational Oceanic and Atmospheric Administration -
A universal eye drop adherence monitor to measure and improve adherence to ocular medications
SBC: Universal Adherence LLC Topic: NProject Summary Abstract Universal Adherence is an emerging medical device company dedicated to improving adherence to ocular medications through innovative technical solutionsOur proposed Devers Drop DeviceDwill accurately track when a patient removes an eye drop bottle capcommunicate usage data wirelessly to a database that researchers can accessand send alerts to patients when a medication is d ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of a Yellow Fever Vaccine for a Vulnerable Population
SBC: NAJIT TECHNOLOGIES INC Topic: NIAIDABSTRACT Yellow fever virus (YFV) represents a mosquito-borne emerging/re-emerging human pathogen that causes 20- 50% mortality and is endemic in andgt;40 countries. The current live attenuated YFV vaccine was developed in 1936 and following the establishment of a virus seed lot system, it has not been modified or otherwise improved in over 50 years. According to the CDC, this vaccine causes 47 se ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Advancing Human Health by Lowering Barriers to Electrophysiology in Genetic Model Organisms
SBC: NEMAMETRIX, INC Topic: 300Project Summary The nematode worm Caenorhabditis elegans has proven valuable as a model for many high impact medical conditionsThe strength of Celegans derives from the extensive homologies between human and nematode genesand the many powerful tools available to manipulate genes in Celegansincluding expressing human genesResearchers utilizing medical models based on Celegans have converged on two ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Factor XI inhibitor for thrombosis
SBC: ARONORA INC Topic: NHLBIProject Summary Although potent antithrombotic agents are availableall of these drugs inadvertently target vital hemostatic molecular mechanismsresulting in dose limiting hemorrhagic toxicity that restrict their useDue to a lack of safe thromboprophylaxisthrombotic blood vessel occlusions continue to be extremely prevalentand result in a wide range of severe disease conditions that remain the lead ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Stage-Based Mobile Intervention for Substance Use Disorders in Primary Care: Implementation and Cluster-Randomized Trial
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDANearlymillion Americans ageand olderneed treatment for a substance use disorderSUDWhile onlyof individuals requiring treatment for a SUD receive itan estimated two thirds see a primary care or urgent care provider everymonthsPrimary care providers are in a unique position to perform ScreeningBrief Interventionand Referral to TreatmentSBIRTWith Phase I contract fundingPro Change developed and pilot ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A cost-effective robotic platform for on-demand production of flexibly dosed medications in a chewable gummy dosage form
SBC: Vitae Industries, Inc. Topic: NICHDPROJECT SUMMARYThis project s goal is to develop an innovative cost effective robotic platform for fast on demand pharmacy production of pediatric drugs as individually tailored palatable gummy dosage formsMedication adherence is notoriously low among children due to difficulty swallowing pills and rejection of bad tasting medicationsAlthough some common pediatric drugs have flavored liquid formsp ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Mobility Rehab: A Biofeedback System for Mobility Rehabilitation for Older Adults
SBC: APDM, INC. Topic: NIAProject Summary Mobility limitations including gait and balance impairments are common in older adultsespecially those with neurological de citsGait and balance impairments are a major cause of falls and reduced quality of lifeAlthough laboratory studies show that biofeedback during exercise training can improve motor performancephysical therapists do not have access to an overground gait biofeedb ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
HLS-Affordable, quantitative microchip-electrophoresis for sickle cell disease screening
SBC: HEMEX HEALTH INC Topic: NHLBIPROJECT SUMMARY Sickle Cell DiseaseSCDaffectsAmericans and more thanmillion people globallyprimarily in economically disadvantaged populationsIt is estimated that nearlyof children born with SCD in these areas die before the age of fivealthoughcould be saved through simplecost effective treatments if diagnosed early according to World Health OrganizationEarly diagnosis of SCD remains a challenge i ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
NeuroPredict, A screening assay for chemicals that affect the differentiation of human neural cells.
SBC: NZUMBE INC Topic: NIEHSABSTRACT A growing human health concern is that exposure to chemicals in our environment harms the highly vulnerable period of human brain developmentIndeedincreasing evidence shows that even simpleacute exposures of the developing brain to select agents cause profound neurological disorders such as epilepsyautism and intellectual disabilityDespite this vulnerabilitythe reliablehigh throughput ide ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health